(TROX) Tronox Holdings - Ratings and Ratios
Titanium Dioxide, Zircon, Pig Iron, Monazite, Titanium Tetrachloride
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 8.03% |
| Yield on Cost 5y | 2.97% |
| Yield CAGR 5y | 15.60% |
| Payout Consistency | 86.7% |
| Payout Ratio | 15.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 60.6% |
| Value at Risk 5%th | 89.0% |
| Relative Tail Risk | -10.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.54 |
| Alpha | -76.94 |
| CAGR/Max DD | -0.34 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.410 |
| Beta | 1.926 |
| Beta Downside | 1.638 |
| Drawdowns 3y | |
|---|---|
| Max DD | 84.48% |
| Mean DD | 37.46% |
| Median DD | 29.95% |
Description: TROX Tronox Holdings October 21, 2025
Tronox Holdings plc (NYSE:TROX) is a vertically integrated producer of titanium dioxide (TiO₂) pigment, operating mines, beneficiation, and smelting facilities across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Its product portfolio includes standard TiO₂ pigment, ultrafine specialty TiO₂, zircon, high-purity pig iron, monazite, feedstock, and titanium tetrachloride, which serve end-markets such as paints, coatings, plastics, and paper. The company was incorporated in 2018 and is headquartered in Stamford, Connecticut.
Key recent metrics: • 2023 revenue was approximately $2.1 billion, with an adjusted EBITDA margin of ~13%, reflecting stable pricing in the TiO₂ market. • Production capacity stands at roughly 1.2 million metric tons of TiO₂ pigment, of which ~85% is currently utilized, indicating modest excess capacity that could absorb demand spikes. • The 2021 acquisition of Cristal expanded Tronox’s North-American footprint and added ~30% to its pigment capacity, making the firm one of the top three global TiO₂ producers. • Sector drivers include construction and automotive coating demand, which together account for about 55% of TiO₂ consumption, and tightening environmental regulations that favor higher-purity, low-VOC pigment formulations.
For a deeper quantitative dive, consider reviewing ValueRay’s detailed cost-structure and margin forecasts for TROX to gauge how these drivers may translate into future earnings.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-324.0m TTM) > 0 and > 6% of Revenue (6% = 170.6m TTM) |
| FCFTA -0.06 (>2.0%) and ΔFCFTA -6.11pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 51.37% (prev 45.46%; Δ 5.91pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 21.0m > Net Income -324.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.22b) to EBITDA (302.7m) ratio: 10.64 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.72 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (158.6m) change vs 12m ago 0.32% (target <= -2.0% for YES) |
| Gross Margin 12.20% (prev 14.92%; Δ -2.71pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 45.53% (prev 49.81%; Δ -4.29pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.07 (EBITDA TTM 302.7m / Interest Expense TTM 176.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.52
| (A) 0.23 = (Total Current Assets 2.31b - Total Current Liabilities 847.0m) / Total Assets 6.30b |
| (B) 0.03 = Retained Earnings (Balance) 213.0m / Total Assets 6.30b |
| (C) 0.00 = EBIT TTM 11.7m / Avg Total Assets 6.25b |
| (D) -0.11 = Book Value of Equity -536.0m / Total Liabilities 4.71b |
| Total Rating: 1.52 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 19.67
| 1. Piotroski 1.0pt |
| 2. FCF Yield -9.31% |
| 3. FCF Margin -12.97% |
| 4. Debt/Equity 2.18 |
| 5. Debt/Ebitda 10.64 |
| 6. ROIC - WACC (= -3.33)% |
| 7. RoE -19.51% |
| 8. Rev. Trend -55.44% |
| 9. EPS Trend -79.75% |
What is the price of TROX shares?
Over the past week, the price has changed by -6.64%, over one month by +46.80%, over three months by -8.77% and over the past year by -54.36%.
Is TROX a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the TROX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4.8 | 10.6% |
| Analysts Target Price | 4.8 | 10.6% |
| ValueRay Target Price | 3.6 | -17.4% |
TROX Fundamental Data Overview December 16, 2025
P/E Forward = 21.8341
P/S = 0.2604
P/B = 0.4743
Beta = 1.173
Revenue TTM = 2.84b USD
EBIT TTM = 11.7m USD
EBITDA TTM = 302.7m USD
Long Term Debt = 3.14b USD (from longTermDebt, last quarter)
Short Term Debt = 124.0m USD (from shortTermDebt, last quarter)
Debt = 3.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.22b USD (from netDebt column, last quarter)
Enterprise Value = 3.96b USD (740.4m + Debt 3.41b - CCE 185.0m)
Interest Coverage Ratio = 0.07 (Ebit TTM 11.7m / Interest Expense TTM 176.0m)
FCF Yield = -9.31% (FCF TTM -369.0m / Enterprise Value 3.96b)
FCF Margin = -12.97% (FCF TTM -369.0m / Revenue TTM 2.84b)
Net Margin = -11.39% (Net Income TTM -324.0m / Revenue TTM 2.84b)
Gross Margin = 12.20% ((Revenue TTM 2.84b - Cost of Revenue TTM 2.50b) / Revenue TTM)
Gross Margin QoQ = 7.44% (prev 10.81%)
Tobins Q-Ratio = 0.63 (Enterprise Value 3.96b / Total Assets 6.30b)
Interest Expense / Debt = 1.41% (Interest Expense 48.0m / Debt 3.41b)
Taxrate = -8.70% (negative due to tax credits) (8.00m / -92.0m)
NOPAT = 12.7m (EBIT 11.7m * (1 - -8.70%)) [negative tax rate / tax credits]
Current Ratio = 2.72 (Total Current Assets 2.31b / Total Current Liabilities 847.0m)
Debt / Equity = 2.18 (Debt 3.41b / totalStockholderEquity, last quarter 1.56b)
Debt / EBITDA = 10.64 (Net Debt 3.22b / EBITDA 302.7m)
Debt / FCF = -8.73 (negative FCF - burning cash) (Net Debt 3.22b / FCF TTM -369.0m)
Total Stockholder Equity = 1.66b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.14% (Net Income -324.0m / Total Assets 6.30b)
RoE = -19.51% (Net Income TTM -324.0m / Total Stockholder Equity 1.66b)
RoCE = 0.24% (EBIT 11.7m / Capital Employed (Equity 1.66b + L.T.Debt 3.14b))
RoIC = 0.27% (NOPAT 12.7m / Invested Capital 4.69b)
WACC = 3.60% (E(740.4m)/V(4.15b) * Re(13.11%) + D(3.41b)/V(4.15b) * Rd(1.41%) * (1-Tc(-0.09)))
Discount Rate = 13.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.57%
Fair Price DCF = unknown (Cash Flow -369.0m)
EPS Correlation: -79.75 | EPS CAGR: -66.59% | SUE: -2.94 | # QB: 0
Revenue Correlation: -55.44 | Revenue CAGR: -6.07% | SUE: -2.27 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.21 | Chg30d=-0.077 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=-0.47 | Chg30d=-0.115 | Revisions Net=-7 | Growth EPS=+60.2% | Growth Revenue=+2.8%
Additional Sources for TROX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle